nach oben

European Radiology

Erschienen in:

16.03.2023 | Editorial

MRI fat fraction imaging of nodal and bone metastases in prostate cancer

verfasst von: Cathy Qin, Olivia Goldberg, Geetanjali Kakar, Simon Wan, Athar Haroon, Aishah Azam, Sola Adeleke

Erschienen in: European Radiology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Key Points

• Characterisation and quantification of tissue fat on MRI can be used to provide information on disease processes.

• Fat in bone and lymph nodes up until recently have not been exploited for diagnostic purposes or response monitoring in prostate cancer.

• Fat imaging on MRI using Dixon/PDFF sequences has the potential to add clinical value in the future but prospective data is needed.

Turkbey B, Brown AM, Sankineni S, Wood BJ, Pinto PA, Choyke PL (2016) Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer J Clin 66(4):326–336CrossRefPubMed

Turpin A, Girard E, Baillet C et al (2020) Imaging for Metastasis in Prostate Cancer: A Review of the Literature. Front Oncol 10:55. https://doi.org/10.3389/fonc.2020.00055

Ghafoor S, Burger IA, Vargas AH (2019) Multimodality Imaging of Prostate Cancer. J Nucl Med 60(10):1350–1358CrossRefPubMedPubMedCentral

Wang Y, Galante JR, Haroon A et al (2022) The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer. Nat Rev Urol 19(8):475–493CrossRefPubMed

Van Damme J, Tombal B, Collette L et al (2021) Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer. Cancers (Basel) 13(21):5286. https://doi.org/10.3390/cancers13215286

Zhan Y, Zhang G, Li M, Zhou X (2021) Whole-Body MRI vs. PET/CT for the detection of bone metastases in patients with prostate cancer: a systematic review and meta-analysis. Front Oncol 11:633833. https://doi.org/10.3389/fonc.2021.633833

Lecouvet FE, Pasoglou V, Van Nieuwenhove S et al (2020) Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer. Eur Radiol 30(6):3083–3093CrossRefPubMed

Pasoglou V, Michoux N, Tombal B, Lecouvet F (2016) Optimising TNM Staging of Patients with Prostate Cancer Using WB-MRI. J Belg Soc Radiol 100(1):101CrossRefPubMedPubMedCentral

Ma J (2008) Dixon techniques for water and fat imaging. J Magn Reson Imaging 28(3):543–558CrossRefPubMed

10.

Bray TJ, Chouhan MD, Punwani S, Bainbridge A, Hall-Craggs MA (2018) Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology. Br J Radiol 91(1089):20170344PubMed

11.

Reeder SB, Hu HH, Sirlin CB (2012) Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. J Magn Reson Imaging 36(5):1011–1014CrossRefPubMedPubMedCentral

12.

Ajmera V, Park CC, Caussy C et al (2018) Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 155(2):307–10.e2CrossRefPubMed

13.

Latifoltojar A, Hall-Craggs M, Rabin N et al (2017) Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response. Br J Haematol 176(2):222–233CrossRefPubMed

14.

Schmeel FC, Luetkens JA, Wagenhäuser PJ et al (2018) Proton density fat fraction (PDFF) MRI for differentiation of benign and malignant vertebral lesions. Eur Radiol 28(6):2397–2405CrossRefPubMed

15.

Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247CrossRefPubMed

16.

Gross BH, Glazer GM, Orringer MB, Spizarny DL, Flint A (1988) Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance. Radiology. 166(1 Pt 1):71–74CrossRefPubMed

17.

Adeleke S (2019) Fat fraction provides classification and treatment response assessment of metastatic lymph nodes for patients with radio-recurrent prostate cancer. Presented at: ISMRM 27th Annual Meeting and Exhibition, Montreal

18.

Zarzour JG, Galgano S, McConathy J, Thomas JV, Rais-Bahrami S (2017) Lymph node imaging in initial staging of prostate cancer: An overview and update. World J Radiol 9(10):389–399CrossRefPubMedPubMedCentral

19.

Adeleke S, Latifoltojar A, Sidhu H et al (2019) Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole–body magnetic resonance imaging in radio-recurrent prostate cancer. BMC Med Imaging 19(1):90CrossRefPubMedPubMedCentral

20.

Messiou C, Cook G, deSouza NM (2009) Imaging metastatic bone disease from carcinoma of the prostate. Br J Cancer 101(8):1225–1232CrossRefPubMedPubMedCentral

21.

Padhani AR, Gogbashian A (2011) Bony metastases: assessing response to therapy with whole-body diffusion MRI. Cancer Imaging 11 Spec No A(1a):S129-45

22.

Raya JG, Dietrich O, Reiser MF, Baur-Melnyk A (2005) Techniques for diffusion-weighted imaging of bone marrow. Eur J Radiol 55(1):64–73CrossRefPubMed

23.

O’Callaghan J, Johnston E, Latifoltojar A et al (2017) Improved lymph node staging using MRI mDixon fat fraction measurements in patients with intermediate and high-risk prostate cancer. ISMRM 25th Annual Meeting & Exhibition Conference

24.

Appayya MB, O’Callaghan J, Latifoltojar A et al (2018) Quantitative mDixon Fat Fraction can differentiate metastatic nodes from benign nodes in prostate cancer patients. Proc Int Soc Mag Reson Med 26:0721

25.

Adeleke S (2020) Qualitative and quantitative whole-body MRI assessment of metastatic disease in patients with radio-recurrent prostate cancer [Dissertation on the internet]. United Kingdom: University College London. https://discovery.ucl.ac.uk/id/eprint/10119042

26.

Perez-Lopez R, Nava Rodrigues D, Figueiredo I et al (2018) Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease: Correlation With Bone Biopsy Histological and Molecular Features. Invest Radiol 53(2):96–102CrossRefPubMedPubMedCentral

27.

Kossov F, van Steenbergen T, Smits M et al (2019) Detection and differentiation of bone metastases in castration resistant prostate cancer (CRPC) patients using 68Ga-PSMA-PET/CT and MR molecular imaging compared to bone biopsy histology as a gold standard. A pilot study: Part I. European Congress of Radiology-ECR

28.

Yoo HJ, Hong SH, Kim DH et al (2017) Measurement of fat content in vertebral marrow using a modified dixon sequence to differentiate benign from malignant processes. J Magn Reson Imaging 45(5):1534–1544CrossRefPubMed

29.

Donners R, Obmann MM, Boll D, Gutzeit A, Harder D (2020) Dixon or DWI – Comparing the utility of fat fraction and apparent diffusion coefficient to distinguish between malignant and acute osteoporotic vertebral fractures. Eur J Radiol 132:109342CrossRefPubMed

30.

Kwack KS, Lee HD, Jeon SW, Lee HY, Park S (2020) Comparison of proton density fat fraction, simultaneous R2*, and apparent diffusion coefficient for assessment of focal vertebral bone marrow lesions. Clin Radiol 75(2):123–130CrossRefPubMed

Titel: MRI fat fraction imaging of nodal and bone metastases in prostate cancer
verfasst von: Cathy Qin
Olivia Goldberg
Geetanjali Kakar
Simon Wan
Athar Haroon
Aishah Azam
Sola Adeleke
Publikationsdatum: 16.03.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 8/2023
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-023-09527-x

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

MRI fat fraction imaging of nodal and bone metastases in prostate cancer

Key Points

Neu im Fachgebiet Radiologie

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

Darf man die Behandlung eines Neonazis ablehnen?

Update Radiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Key Points

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2023

Real world impact of added FFR-CT to coronary CT angiography on clinical decision-making and patient prognosis – IMPACT FFR study

Assessment of liver fibrosis using a 3-dimensional high-resolution late gadolinium enhancement sequence in children and adolescents with Fontan circulation

Infliximab response associates with radiologic findings in bio-naïve Crohn’s disease

Histogram analysis of quantitative parameters from synthetic MRI: correlations with prognostic factors in nasopharyngeal carcinoma

Virtual monochromatic images for coronary artery imaging with a spectral photon-counting CT in comparison to dual-layer CT systems: a phantom and a preliminary human study

Intravoxel incoherent motion diffusion weighted imaging for preoperative evaluation of liver regeneration after hepatectomy in hepatocellular carcinoma

Neu im Fachgebiet Radiologie

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Klinikreform soll zehntausende Menschenleben retten

Darf man die Behandlung eines Neonazis ablehnen?

Update Radiologie